UNSPSC 51162026: Ephedrine/phenobarbital/potassium iodide/theophylline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162026 Ephedrine/phenobarbital/potassium iodide/theophylline is a Commodity code under which state and local governments procure pharmaceutical products, naloxone emergency response supplies, and on-site pharmacy services for public health and employee health benefit programs. Recent solicitations show purchasing activity spanning emergency pharmaceutical supplies (naloxone and drug deactivation systems), employer-based pharmacy benefit administration, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals for distribution through state and cooperative purchasing networks. Issuing bodies include county health departments, county government employee health programs, state health and human services agencies, and regional cooperative purchasing alliances that aggregate demand across multiple state and local jurisdictions. The code's scope in practice encompasses both emergency-response pharmaceuticals managed by public health entities and routine prescription and over-the-counter pharmaceutical procurement by employer health plans and state benefit programs.

Recent activity concentrates in Florida, Georgia, Texas, and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administering a multi-state RFP covering Oregon and other participating jurisdictions. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually (response due July 26, 2023, though the date appears erroneous in source records); Hall County, Georgia released RFQ/P #47-010 on May 4, 2026 seeking an on-site pharmacy services provider to serve approximately 3,005 eligible employees and retirees at the Hall County Government Family Health Center Clinic, with sealed proposals due June 4, 2026; the Texas Health and Human Services Commission issued RFI No. HHS0017013 on April 3, 2026 to gather vendor intelligence on direct-to-manufacturer prescription programs; and the Minnesota Department of Administration's MMCAP issued an RFP on January 20, 2026 for generic multi-source pharmaceuticals and over-the-counter products through authorized wholesalers, with proposals due March 26, 2026 and awards effective July 1, 2026. No set-aside designations appear in recent solicitations.